Statement: 1 patient in the primary trial suffered from a blood clot blocking their blood vessels.
Primary_evidence: Adverse Events 1:   Total: 10/31 (32.26%)   Edema, limb 1/31 (3.23%)   Thrombosis1/31 (3.23%)   diarrhea1/31 (3.23%)   Pain 2/31 (6.45%)   Pain, back1/31 (3.23%)   Pain, extrimity limb 1/31 (3.23%)   Syncope 1/31 (3.23%)   Pain, chest/thorax1/31 (3.23%)   hyponatremia 1/31 (3.23%)   fever1/31 (3.23%)   AST 1/31 (3.23%)   infection1/31 (3.23%)   Anorexia 1/31 (3.23%)   Dyspnea 2/31 (6.45%)